Trial of Sinovac's measles mumps and rubella virus vaccine in China

Trial Profile

Trial of Sinovac's measles mumps and rubella virus vaccine in China

Not yet recruiting
Phase of Trial: Phase I

Latest Information Update: 25 Mar 2015

At a glance

  • Drugs Measles mumps and rubella vaccine Sinovac Biotech (Primary)
  • Indications Measles; Mumps; Rubella
  • Focus Adverse reactions
  • Most Recent Events

    • 25 Mar 2015 New trial record
    • 17 Mar 2015 The clinical trial application for this study of measles mumps and rubella virus vaccine was filed with the China Food and Drug Administration in April 2011, and Sinovac obtained the clinical trial license in December 2014, according to a company media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top